• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Gefarnate Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5752317

Gefarnate is a synthetic compound used for the treatment of gastric ulcers,and also used in the treatment of dry eye syndrome. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Gefarnate, Inhibitor
Full Product Name
Gefarnate
Form/Format
Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder; -80 degree C for 2 years in solvent
For obtaining a higher solubility, please warm the tube at 37 degree C and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20 degree C for several month.
Molecular Weight
400.64
Formula
C27H44O2
CAS
51-77-4
Smiles
CC(C)=CCC\C(C)=C\CC\C(C)=C\CCC(=O)OC\C=C(/C)CCC=C(C)C
Solubility
DMSO: 100mg/mL (249.60mM)
(<1mg/ml refers to the product slightly soluble or insoluble)

Product Categories/Family for Gefarnate, inhibitor

Structure of Gefarnate, inhibitor

Gefarnate Inhibitor – Cat# MBS5752317

Product References and Citations for Gefarnate, inhibitor

1. Dota A, Takaoka-Shichijo Y, Nakamura M. Gefarnate stimulates mucin-like glycoprotein secretion in conjunctival tissue and ameliorates corneal epithelial damage in animal dry-eye models[J]. Clinical ophthalmology (Auckland, N.Z.), 2013, 7 (default):211-217.
2. Ohta Y, Kobayashi T, Imai Y, et al. Effect of Gefarnate on Acute Gastric Mucosal Lesion Progression in Rats Treated with Compound 48/80, a Mast Cell Degranulator, in Comparison with That of Teprenone[J]. Biological & Pharmaceutical Bulletin, 2005, 28 (8):1424-1430.
3. Du Y Q, Su T, Hao J Y, et al. Gastro-protecting effect of gefarnate on chronic erosive gastritis with dyspeptic symptoms[J]. Chinese Medical Journal, 2012, 125.

Other Notes

Small volumes of Gefarnate, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Gefarnate purchase

MBS5752317 is an inhibitor targeting Gefarnate.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000